price target cut at Credit Suisse. CTXS price target lowered to $47.50 from $50 on disappointing results with weak XenDesktop bookings. Maintain Neutral rating.
numbers raised at UBS. Shares of CY now seen reaching $13. Estimates also increased, as touch controller sales are driving higher margins. Neutral rating.
price target lifted at Credit Suisse. CYMI price target raised to $40 from $38 as share gains at Samsung help an otherwise mixed quarter. Maintain Outperform rating.
estimates, target increased at Morgan Stanley. DHR estimates were raised through 2012. Company posted double-digit core growth and is running at a record gross margin. Overweight rating and new $50 price target.
target raised at Morgan Stanley to $43. Company can generate 17%-20% annual earnings growth over the next two years. Overweight rating.
estimates reduced at Morgan Stanley through 2012. Operators are shifting toward newbuild rigs. Underweight rating and $57 price target.
ITT Educational Services
numbers cut at Credit Suisse. ESI price target reduced to $50 from $57. Weak 3Q results showed that concerns about start issues may worsen. 2010 and 2011 EPS estimates dropped to $11.11 and $10, respectively. Neutral rating.
numbers cut at UBS. Shares of ESI now seen reaching $60. Estimates also reduced, given regulatory uncertainty. Neutral rating.
estimates boosted at Barclays. FSLR 2010 and 2011 EPS estimates increased to $7.60 and $8.55, respectively. Expecting strong 3Q10 results with upbeat 2011 outlook. Maintain Equal Weight rating and $140 price target.
estimates, target boosted at Morgan Stanley. Shares of FTNT now seen reaching $30. Estimates also upped, given better traction for UTM and the company's solid market position. Overweight rating.
numbers increased at Citigroup. HSY estimates were raised through 2011. Company has better visibility heading into the new year. Buy rating and new $60 price target.
estimates, target increased at Morgan Stanley. HUB.B estimates were raised through 2012. Company is seeing better demand for industrial and high-voltage test equipment. Equal-weight rating and new $57 price target.
estimates, target lowered at Morgan Stanley. Shares of K now seen reaching $54. Estimates also reduced, as the company is struggling to deliver in a difficult operating environment. Overweight rating.
estimates, target boosted at UBS. Shares of MCD now seen reaching $86. Estimates also upped, as sales growth is accelerating. Buy rating.